Medical and Pharmaceutical

The achievement was announced as Lung Cancer Awareness Month begins

This pharmaceutical company is also developing a synthetic cannabinoid drug to treat anxiety and cognitive decline

This €4.9-million-euro initiative is being funded by the Irish Cancer Society

Lazertinib, developed in partnership with Janssen Biotech, received FDA approval in August

Analysts at Cantor Fitzgerald and JP Morgan Chase & Co recently gave the company an overweight rating

It is being implemented before Lung Cancer Awareness Month in November

Studies by the institution have shown that Indigenous people in the U.S. have a 73% higher cancer mortality rate than others

Developing drugs for the treatment of epilepsy, depression, obesity and other conditions is the company's forte

Lung cancer remains the leading cause of cancer-related deaths in Canada, effecting one in 14 Canadians

Some studies have indicated that it can, along with other cancers

The Swiss oncology company's stock rose by over 33% as a result

RNA editing involves modifying RNA to correct or alter protein production in the body

Tylee Craft was diagnosed with stage 4 large cell neuroendocrine carcinoma in 2022

The Israeli company has used its proprietary Alpha DaRT treatment for other cancers but not lung

The University of California says 15 veterans die from lung cancer around the world every day

The SAPPHIRE study demonstrated statistically significant and clinically meaningful improvements

The consortium is affiliated with the World Health Organization

The biotech company will be revealing 3-year safety data on its primary drug for Duchenne muscular dystrophy next week

About 900,000 are at risk of contracting the disease, the department says

The state is tailoring its program after Kentucky's successful model

The study analyzed CT scans from over 10,000 participants and found at least one lung nodule in 42 per cent of them

The biotech company is giving up on a leukemia drug and shifting focus to a bowel disease treatment

This oncology tech company has created the proprietary "Proclarix" blood test for diagnosing prostate cancer

These trucks will complete thousands of CT scans and pulmonary function tests annually

Combatting air pollution and quitting smoking are also key themes

The nation introduced a proposal to the WHO for global prioritization of lung health

Duchenne muscular dystrophy is a severe, progressive genetic disorder that primarily affects boys

Their findings have been published in the Royal Society of Chemistry's Analyst journal

Progyny's termination by the unnamed client in January will result in a 13% loss of revenue, approximately

The company stock rose 55 per cent after results of one dose show immediate results

Kentucky has more cases of lung cancer than any other state, but it has one of the highest screening rates

This "Ion Endoluminal System" enables doctors to access hard-to-reach areas of the lungs

Screening men for BCL2 could allow for the development of personalized treatment plans

This will be the first time that labs in Atlantic Canada utilize liquid biopsies to test for the disease

The drug in question is also presently being tested in an ongoing dose-escalation Phase 1 trial for patients with solid tumours

Instil Bio stock rose by nearly 57% on Thursday due to this prediction and other recent developments

Veligrotug’s response rate and metrics suggest competitive, and potentially superior, performance than drug presently on the market

"Dato-DXd" was thought to have immense potential but now appears to be a disappointment

Analysts have now given the company a much higher share target price too

Every year five million people who should get checked out do not, the health service says